Skip to main content Help with accessibility Skip to main navigation

Tirzepatide for managing overweight and obesity (NICE TA1026)

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 24 - Feb - 2025
Body System:
Red
Tirzepatide for managing overweight and obesity (NICE TA1026)

The Cheshire and Merseyside Area Prescribing Group recommend the prescribing of tirzepetide in accordance with NICE Technology Appraisal (TA) 1026.

This temporary red statement applies to the initial 3 month implementation period for patients accessing specialist weight management services.

NHS Cheshire and Merseyside APPROVED